Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

REGNREGN
3 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in Regeneron Pharmaceuticals, Inc.

As of its last 13F, for Q2 2024, BlackRock Finance held 8,446,366 shares of REGN (Regeneron Pharmaceuticals), worth $8.9B. It reduced the position by 122,288 shares (-1.4%) from Q1 2024. BlackRock Finance held REGN from Q4 2023 to Q2 2024, across 3 quarterly 13F filings. REGN was 0.2% of BlackRock Finance's reported 13F portfolio.

Current Value

$8.9B

Current Shares

8.4M

Total Value Change

+$1.3B

Total Shares Change

-183,341

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Decreased
8.4M
-1.4%
$8.9B0.2%$1,041.20
0
2024-Q1
Decreased
8.6M
-0.7%
$8.2B0.2%$953.49
0
2023-Q4
First report
8.6M
-
$7.6B0.2%$870.08
0

Other major holders of REGN: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used